RETeval™ is a handheld DR screening device that enables virtually any health care provider to screen for sight-threatening DR in less than three minutes per patient with no dilation regardless of ...

A new study shows how the hand-held device RETeval may prove to be a more accessible way to diagnose schizophrenia, predict relapse and symptom severity, and assess treatment effectiveness. A portable ...

Point-of-care diagnostics company Welch Allyn and visual electrophysiology player LKC Technologies have signed an exclusive partnership for the former to distribute the latter's RETeval DR device, ...

More than 400 diabetic patients have been evaluated using the RETeval® a handheld diabetic retinopathy screening device, announced LKC Technologies. RETeval lets a healthcare provider screen a ...

Currently, in order to make a diagnosis of schizophrenia, a doctor must assess a patient's reported symptoms … which can be somewhat subjective. According to a recent study, however, an existing ...

GAITHERSBURG, Md., April 28, 2014 /PRNewswire/ --A rigorous multi-center clinical trial has completed testing over 400 diabetic patients to evaluate the effectiveness of RETeval® based visual ...

Early adopters have hailed the RETeval Complete as being useful for ophthalmologists treatinf children with uncertain visual potential. 1. RETeval Complete is one of the first non-mydriatic, ...

GAITHERSBURG, Md., Dec. 4, 2014 /PRNewswire/ -- Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and LKC Technologies, Inc., the ...

GAITHERSBURG, Md., April 28, 2014 /PRNewswire/ -- A rigorous multi-center clinical trial has completed testing over 400 diabetic patients to evaluate the effectiveness of RETeval(R) based visual ...